Morris Animal Foundation Awards 17 Grants to Fund Diverse Set of Equine Health Studies
Morris Animal Foundation Launches $1.2 Million Initiative to Fight Deadly Disease of Cats
Assessing Immune Stimulation as a Potential Therapy for Osteosarcoma
This study will characterize the expression of toll-like receptors, which activate the immune system, in canine osteosarcoma cells to better determine the biological consequences associated with activating these receptors.
Testing Strategies to Treat Drug-Resistant Hemangiosarcomas
Investigators are assessing the potential for a specific tumor-cell population in canine hemangiosarcoma to sequester drugs within their lysosomes as a novel mechanism of drug resistance.
Assessing the NDY1 Protein as a Potential Treatment for Mast Cell Cancer
The goal of this study is to determine new strategies for treating canine mast cell tumors based on the targeting of a DNA-packaging protein called NDY1.
Developing a Way to Predict Length of Disease-Free Intervals for Dogs with Bone Cancer
This study investigates how cytogenetic changes in canine osteosarcoma affect the duration of disease-free interval when patients are treated with amputation followed by doxorubicin and non-cytotoxic suramin.
Determining How Overexpression of miR-9 Helps Osteosarcoma Spread
This study will provide a molecular framework for understanding the process of miR-9-driven tumor spread in canine osteosarcoma, thereby generating potential new targets for therapy to prevent or treat tumor spread in this devastating disease.
Understanding How Mammary Cancer Develops
This study investigates the role of citrullination in canine mammary cancer and how interfering with this process might lead to more effective anticancer treatments.
Identifying Genetic Mutations That Cause Extrahepatic Portosystemic Shunts in Dogs
This study will determine the genetic and functional differences of eight genes that are strongly associated with congenital extrahepatic portosystemic shunts in several small dog breeds.